These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 35140181)

  • 21. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
    Soler D; Chapman TR; Poisson LR; Wang L; Cote-Sierra J; Ryan M; McDonald A; Badola S; Fedyk E; Coyle AJ; Hodge MR; Kolbeck R
    J Immunol; 2006 Nov; 177(10):6940-51. PubMed ID: 17082609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epitope Mapping of an Anti-Mouse CCR8 Monoclonal Antibody C
    Kobayashi H; Suzuki H; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Aug; 43(4):101-107. PubMed ID: 38836509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
    Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
    Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.
    Ko K; Yamazaki S; Nakamura K; Nishioka T; Hirota K; Yamaguchi T; Shimizu J; Nomura T; Chiba T; Sakaguchi S
    J Exp Med; 2005 Oct; 202(7):885-91. PubMed ID: 16186187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.
    Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE
    Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells.
    Weiss VL; Lee TH; Song H; Kouo TS; Black CM; Sgouros G; Jaffee EM; Armstrong TD
    PLoS One; 2012; 7(2):e31962. PubMed ID: 22359647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
    Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD25-targeted antibody-drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity.
    Zammarchi F; Havenith K; Bertelli F; Vijayakrishnan B; Chivers S; van Berkel PH
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32912922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR8
    Barsheshet Y; Wildbaum G; Levy E; Vitenshtein A; Akinseye C; Griggs J; Lira SA; Karin N
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6086-6091. PubMed ID: 28533380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
    Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
    PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.
    Aida K; Miyakawa R; Suzuki K; Narumi K; Udagawa T; Yamamoto Y; Chikaraishi T; Yoshida T; Aoki K
    Cancer Sci; 2014 Feb; 105(2):159-67. PubMed ID: 24289533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy.
    Tay C; Tanaka A; Sakaguchi S
    Cancer Cell; 2023 Mar; 41(3):450-465. PubMed ID: 36917950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease.
    Coghill JM; Fowler KA; West ML; Fulton LM; van Deventer H; McKinnon KP; Vincent BG; Lin K; Panoskaltsis-Mortari A; Cook DN; Blazar BR; Serody JS
    Blood; 2013 Aug; 122(5):825-36. PubMed ID: 23798714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrete TCR repertoires and CDR3 features distinguish effector and Foxp3+ regulatory T lymphocytes in myelin oligodendrocyte glycoprotein-induced experimental allergic encephalomyelitis.
    Nguyen P; Liu W; Ma J; Manirarora JN; Liu X; Cheng C; Geiger TL
    J Immunol; 2010 Oct; 185(7):3895-904. PubMed ID: 20810983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquisition of suppressive function by conventional T cells limits antitumor immunity upon T
    Whiteside SK; Grant FM; Alvisi G; Clarke J; Tang L; Imianowski CJ; Zhang B; Evans AC; Wesolowski AJ; Conti AG; Yang J; Lauder SN; Clement M; Humphreys IR; Dooley J; Burton O; Liston A; Alloisio M; Voulaz E; Langhorne J; Okkenhaug K; Lugli E; Roychoudhuri R
    Sci Immunol; 2023 Dec; 8(90):eabo5558. PubMed ID: 38100544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
    Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
    Front Immunol; 2021; 12():619932. PubMed ID: 33868236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4⁺ T cells expressing latency-associated peptide and Foxp3 are an activated subgroup of regulatory T cells enriched in patients with colorectal cancer.
    Mahalingam J; Lin CY; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Lin YC
    PLoS One; 2014; 9(9):e108554. PubMed ID: 25268580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.